Science Explorer Interactive view Map
Nonprofit · Islamabad · Pakistan

Nuclear Threat Initiative

Research works
4
fractional, all time
Citations
6
1.6 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
87%
world 28%

Not ranked overall: Nuclear Threat Initiative is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Nuclear Threat Initiative publish most on?

By volume in 2022–2025: Retinal and Optic Conditions, Rice Cultivation and Yield Improvement, Immunodeficiency and Autoimmune Disorders and Genetics and Plant Breeding.

  1. 1 Retinal and Optic Conditions Ophthalmology 0 works
  2. 2 Rice Cultivation and Yield Improvement Plant Science 0 works
  3. 3 Immunodeficiency and Autoimmune Disorders Immunology 0 works
  4. 4 Genetics and Plant Breeding Plant Science 0 works
  5. 5 Wheat and Barley Genetics and Pathology Plant Science 0 works
  6. 6 Crop Yield and Soil Fertility Agronomy and Crop Science 0 works
  7. 7 Autoimmune Bullous Skin Diseases Pathology and Forensic Medicine 0 works
  8. 8 Platelet Disorders and Treatments Hematology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available87.0%not open13.0%

World: 28% of research is openly available.

with international co-authors47.8%domestic only52.2%

World: 19% is written across borders.

How has Nuclear Threat Initiative's research output changed?

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Islamabad

All research institutions in Islamabad

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.